JERSTRUQ
Live / Registered — Registered (as of 05 Apr 2022)
What this means for you
Registered since 05 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90766054
- Registration number
- 6693831
- Mark type
- Stylized text
- Filed
- 10 Jun 2021
- Published for opposition
- 18 Jan 2022
- Registered
- 05 Apr 2022
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
Prosecution history
- 08 Nov 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Nov 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jan 2022 — PUBLISHED FOR OPPOSITION
- 29 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Dec 2021 — EXAMINER'S AMENDMENT ENTERED
- 15 Dec 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Dec 2021 — EXAMINERS AMENDMENT E-MAILED
- 15 Dec 2021 — EXAMINERS AMENDMENT -WRITTEN
- 09 Dec 2021 — ASSIGNED TO EXAMINER